An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain-Reference-Cited by-同舟云学术

An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain

Published:2020-10 Issue:3 Volume:33 Page:108274
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Wu Nicholas C.,Yuan Meng^ORCID,Liu Hejun^ORCID,Lee Chang-Chun D.,Zhu Xueyong,Bangaru Sandhya^ORCID,Torres Jonathan L.^ORCID,Caniels Tom G.^ORCID,Brouwer Philip J.M.,van Gils Marit J.,Sanders Rogier W.,Ward Andrew B.,Wilson Ian A.

Funder

Bill and Melinda Gates Foundation

National Institutes of Health

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference35 articles.

1. PHENIX: a comprehensive Python-based system for macromolecular structure solution;Adams;Acta Crystallogr. D Biol. Crystallogr.,2010

2. Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients;Andreano;bioRxiv,2020

3. Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies;Barnes;bioRxiv,2020

4. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies;Barnes;Cell,2020

5. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability;Brouwer;Science,2020

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines;Science Immunology;2024-08-09

2. A benchmark for evaluation of structure-based online tools for antibody-antigen binding affinity;Biophysical Chemistry;2024-08

3. An explainable language model for antibody specificity prediction using curated influenza hemagglutinin antibodies;Immunity;2024-08

4. Single-cell multi-omics analysis revealing immune features of inactivated COVID-19 vaccination in systemic lupus erythematosus patients;Science Bulletin;2024-05

5. Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants;Journal of Virology;2023-12-21